比较合并与不合并乙型肝炎病毒感染的肝内胆管癌患者的MRI及预后特征
该回顾性研究纳入2015至2018年间接受术前MRI及根治性手术切除的211例肝内胆管癌患者,比较HBV阳性与阴性组的临床、MRI及预后特征。HBV阳性组更常见单纯肿块型、周边部肿瘤、边缘或非边缘动脉期强化及影像学肝硬化,而胆管侵犯/扩张、次级汇合部受累及胆管周围浸润较少见;两组无复发生存期和总生存期无显著差异,但HBV阳性组肝内复发率更高,且HBV阳性为肝内复发的独立预测因素。
要点
- HBV阳性肝内胆管癌更常见单纯肿块型(91.4% vs 76.9%)和周边部肿瘤(55.5% vs 34.6%)。
- HBV阳性组边缘或非边缘动脉期强化(85.2% vs 68.5%)及影像学肝硬化(19.8% vs 8.5%)更常见。
- HBV阳性组肝内复发率更高(37.0% vs 23.1%),HBV阳性为肝内复发的独立预测因素(OR 1.93,p=0.047)。
核心结论
- HBV相关肝内胆管癌具有独特的MRI特征,且根治性切除后肝内复发率更高。
研究设计与样本
- 回顾性分析2015至2018年间接受术前MRI及根治性手术切除的211例肝内胆管癌患者,由两名放射科医师独立评估MRI特征。
关键影像表现/征象
- HBV阳性组单纯肿块型更常见(91.4% vs 76.9%,p=0.007),HBV阴性组混合型更常见。
- HBV阳性组周边部肿瘤位置更常见(55.5% vs 34.6%,p=0.011)。
- HBV阳性组胆管侵犯/扩张(p<0.001)、次级汇合部受累(p=0.005)及胆管周围肿瘤浸润(p=0.030)较少见。
- HBV阳性组边缘或非边缘动脉期强化更常见(85.2% vs 68.5%,p=0.024)。
- HBV阳性组影像学肝硬化更常见(19.8% vs 8.5%,p=0.017)。
诊断标准与关键数值
- HBV阳性组与HBV阴性组无复发生存期和总生存期无显著差异(p≥0.327)。
- HBV阳性组肝内复发率显著高于HBV阴性组(37.0% vs 23.1%,p=0.029)。
- HBV阳性为肝内复发的独立预测因素(OR 1.93,p=0.047)。
临床应用与阅片要点
- 阅片时注意HBV阳性肝内胆管癌更倾向表现为单纯肿块型、周边部位置、动脉期边缘或非边缘强化,并常伴影像学肝硬化。
- HBV阳性患者胆管侵犯/扩张、次级汇合部受累及胆管周围浸润相对少见,报告时需结合HBV状态综合判断。
- HBV阳性与根治性切除后肝内复发风险升高相关(OR 1.93),随访中应关注肝内复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the clinical, MRI, and prognostic features of intrahepatic cholangiocarcinoma (ICCA) between patients with and without hepatitis B virus (HBV) infection.
METHODS: We retrospectively analyzed 211 patients with ICCA who underwent preoperative MRI and curative-intent surgical resection between 2015 and 2018. Two radiologists independently reviewed MRI features. Clinicopathologic and MRI characteristics were compared according to HBV status. Recurrence-free survival (RFS) and overall survival (OS) were assessed using the Kaplan-Meier method and log-rank test. Recurrence rates were compared according to tumor site, and logistic regression analysis was used to identify independent predictors of intrahepatic recurrence.
RESULTS: Among the 211 patients (mean age, 63.4 ± 10.5 years; 126 men), 81 (38.4%) were HBV-positive and 130 (61.6%) were HBV-negative. The purely mass-forming type of ICCA was more common in the HBV-positive group (91.4% vs. 76.9%; p = 0.007), whereas combined types were more frequent in the HBV-negative group. On MRI, peripheral tumor location was more frequent in the HBV-positive group (55.5% vs. 34.6%; p = 0.011), while bile duct invasion/dilatation (p < 0.001), secondary confluence involvement (p = 0.005), and periductal tumor infiltration (p = 0.030) were less common. Rim or non-rim arterial-phase enhancement (85.2% vs. 68.5%; p = 0.024) and radiologically-evident cirrhosis (19.8% vs. 8.5%; p = 0.017) were more frequent in HBV-positive patients. Although RFS and OS did not significantly differ between the groups (p ≥ 0.327), the intrahepatic recurrence rate was significantly higher in the HBV-positive group (37.0% vs. 23.1%; p = 0.029). HBV positivity was also identified as an independent predictor of intrahepatic recurrence (odds ratio, 1.93; p = 0.047).
CONCLUSION: HBV-associated ICCA demonstrates distinct MRI features and is associated with a higher rate of intrahepatic recurrence following curative resection.
引用
- Choi SJ, Kim DH, Choi SH, et al. Comparison of MRI and prognostic features of intrahepatic cholangiocarcinoma between patients with and without hepatitis B virus infection. Abdom Radiol (NY). 2025. PMID: 40459595. doi:10.1007/s00261-025-05034-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。